UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | G | H | I | J | L | M | N | P | R | S | T | V | W
Number of items: 55.

A

Alberdi, F; Dadone, J; Ryazanov, A; Isenberg, DA; Reichlin, M; (2001) Cross-reaction of lupus Anti-dsDNA antibodies with protein translation factor EF-2. CLIN IMMUNOL , 98 (2) 293 - 300. 10.1006/clim.2000.4970.

B

Bickerstaff, MCM; Isenberg, DA; (2001) An overview of SLE. Rheumatology in the kidney, Oxford University Press pp. 3-16.

Booth, DR; Bellotti, V; Mangione, P; Booth, S; Sunde, M; Serpell, LC; Robinson, CV; ... Hawkins, PN; + view all (2001) Is lysozyme variant Thr70Asn amyloidogenic? AMYLOID , 8 149 - 149.

Brouwer, R; Hengstman, GJ; Vree, EW; Ehrfeld, H; Bozic, B; Ghirardello, A; Grondal, G; ... van Venrooij, WJ; + view all (2001) Autoantibody profiles in the sera of European patients with myositis. Annals of the Rheumatic Diseases , 60 (2) pp. 116-123.

C

Chiti, F; Mangione, P; Andreola, A; Giorgetti, S; Stefani, M; Dobson, CM; Bellotti, V; (2001) Detection of two partially structured species in the folding process of the amyloidogenic protein beta 2-microglobulin. J Mol Biol , 307 (1) pp. 379-391. 10.1006/jmbi.2000.4478.

Coleiro, B; Marshall, SE; Denton, CP; Howell, K; Blann, A; Welsh, KI; Black, CM; (2001) Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine. RHEUMATOLOGY , 40 (9) 1038 - 1043.

D

Dayal, NA; Isenberg, DA; (2001) Assessment of inflammatory myositis. CURR OPIN RHEUMATOL , 13 (6) 488 - 492.

Dean, GS; Anand, A; Blofeld, A; Isenberg, DA; Lydyard, PM; (2001) Functional characterisation of double negative T cells in systemic lupus erythematosus: measurement of spontaneous and mitogen stimulated in vitro interleukin 4 (IL4) production. RHEUMATOLOGY , 40 5 - 5.

Denton, CP; Abraham, DJ; (2001) Transforming growth factor-beta and connective tissue growth factor: key cytokines in scleroderma pathogenesis. CURR OPIN RHEUMATOL , 13 (6) 505 - 511.

Denton, CP; Bing, Z; Xu, SW; Zhang, ZP; Bou-Gharios, G; Eberspaecher, H; Black, CM; (2001) Activation of a fibroblast-specific enhancer of the Pro alpha 2(I) collagen gene in tight-skin mice. ARTHRITIS RHEUM , 44 (3) 712 - 722.

Denton, CP; Black, CM; (2001) Combination therapies for systemic sclerosis. SPRINGER SEMIN IMMUN , 23 (1-2) 109 - 129.

Dobson, CM; Weissmann, C; Pepys, MB; Karplus, M; (2001) Prions and the lymphoreticular system - Discussion. PHILOS T R SOC B , 356 (1406) 184 - 184.

Dodds, WN; Isenberg, DA; (2001) UK regional rheumatology meetings. RHEUMATOLOGY , 40 (12) 1423 - 1423.

Donohoe, S; Mackie, IJ; Isenberg, D; Machin, SJ; (2001) Anti-prothrombin antibodies: Assay conditions and clinical associations in the anti-phospholipid syndrome. British Journal of Haematology , 113 (2) pp. 544-549. 10.1046/j.1365-2141.2001.02716.x.

E

Edwards, JCW; Cambridge, G; (2001) Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes. RHEUMATOLOGY , 40 (2) pp. 205-211. 10.1093/rheumatology/40.2.205.

G

Gillmore, J.D.; Lovat, L.B.; Persey, M.R.; Pepys, M.B.; Hawkins, P.N.; (2001) Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. The Lancet , 358 (9275) pp. 24-29. 10.1016/S0140-6736(00)05252-1.

Gillmore, JD; Apperley, JF; Lachmann, HJ; Barrett, AJ; Madhoo, S; Pepys, MB; Hawkins, PN; (2001) Combination chemotherapy for systemic AL amyloidosis. AMYLOID , 8 72 - 73.

Gillmore, JD; Lovat, LB; Persey, MR; Pepys, MB; Hawkins, PN; (2001) Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. LANCET , 358 (9275) 24 - 29.

H

Hawkins, PN; (2001) 10 years experience with serum amyloid P component scintigraphy. In: AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS. (pp. 166 - 168). PARTHENON PUBLISHING GROUP

Hawkins, PN; (2001) Phenotypes and fibril types in systemic amyloidosts. In: AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS. (pp. 147 - 149). PARTHENON PUBLISHING GROUP

Hawkins, PN; Gallimore, R; Smith, L; Bradwell, AR; Lachmann, HJ; (2001) Highly sensitive automated immunoassay for free immunoglobulin light-chains in diagnosis and follow up of AL amyloidosis. AMYLOID , 8 70 - 71.

Hutchinson, WL; Herbert, J; Botto, M; Walport, MJ; Pepys, MB; (2001) AA amyloid deposition is complement independent. AMYLOID , 8 26 - 27.

I

Imhof, A; Froehlich, M; Brenner, H; Boeing, H; Pepys, MB; Koenig, W; (2001) Effect of alcohol consumption on systemic markers of inflammation. LANCET , 357 (9258) 763 - 767.

J

Joseph, JE; Harrison, P; Mackie, IJ; Isenberg, DA; Machin, SJ; (2001) Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis. British Journal of Haematology , 115 (2) pp. 451-459. 10.1046/j.1365-2141.2001.03101.x.

Joshi, J; Lachmann, HJ; Morris, R; Hawkins, PN; (2001) A comparison of ECG and echocardiographc findings in 500 patients attending an amyloidosis clinic. AMYLOID , 8 161 - 162.

Jury, EC; D'Cruz, D; Morrow, WJW; (2001) Autoantibodies and overlap syndromes in autoimmune rheumatic disease. J CLIN PATHOL , 54 (5) 340 - 347.

L

Lachmann, HJ; Booth, DR; Booth, SE; Bybee, A; Gilbertson, JA; Gillmore, JD; Hawkins, PN; (2001) Hereditary systemic amyloidosis due to variant fibrinogen A alpha-chain is unexpectedly frequent in the British population. AMYLOID , 8 151 - 151.

Lachmann, HJ; Hawkins, PN; (2001) Amyloidosis:Pathogenesis and Diagnosis. In: Adu, D and Emery, P and Madaio, MP, (eds.) Rheumatology and the Kidney. (pp. 305-321). Oxford University Press

Lachmann, HJ; Hawkins, PN; (2001) Amyloidosis:rheumatic disease and amyloid;clinical features and treatment. In: Adu, D and Emery, P and Madaio, MP, (eds.) Rheumatology and the Kidney. (pp. 322-348). Oxford University Press

Leandro, MJ; Isenberg, DA; (2001) Investigating headaches in patients with systemic lupus erythematosus. Acta Rheum Port , 26 pp. 65-72.

Leung, KY; Wait, R; Welson, SY; Yan, YX; Abraham, DJ; Black, CM; Pearson, JD; (2001) A reference map of human lung MRC-5 fibroblast proteins using immobilized pH gradient-isoelectric focusing-based two-dimensional electrophoresis. PROTEOMICS , 1 (6) 787 - 794.

M

Mabbott, N.A.; Bruce, M.E.; Botto, M.; Walport, M.J.; Pepys, M.B.; (2001) Temporary depletion of complement component C3 or genetic deficiency of C1q significantly delays onset of scrapie. Nature Medicine , 7 (4) pp. 485-487. 10.1038/86562.

Mclachlan-Troup, N; Taylor, GW; Trathen, BC; (2001) Diamorphine treatment for opiate dependence: Putative markers of concomitant heroin misuse. Addiction Biology , 6 (3) pp. 223-231. 10.1080/13556210120056553.

Montagna, G; Piazza, V; Banfi, G; Bellotti, V; Segagni, S; Picardi, L; Mangione, P; ... Salvadeo, A; + view all (2001) Hepatitis C virus-associated cryoglobulinaemicglomerulonephritis with delayed appearance ofmonoclonal cryoglobulinaemia. Nephrol Dial Transplant , 16 pp. 432-434.

Moss, KE; Isenberg, DA; (2001) Comparison of renal disease severity and outcome in patients with primary antiphospholipid syndrome, antiphospholipid syndrome secondary to systemic lupus erythematosus (SLE) and SLE alone. RHEUMATOLOGY , 40 (8) 863 - 867.

N

Nardin, R; Lachmann, H; (2001) Familial amyloid polyneuropathy: presentation, diagnosis and treatment. J CLIN NEUROMUSC DIS , 2 pp. 221-226.

Noursadeghi, M; Bickerstaff, M; Herbert, J; Cohen, J; Pepys, M; (2001) Production of Granulocyte Colony Stimulating Factor Enhances Host Resistance to Bacterial Infection in the Acute Phase Response. Clinical Science , 101 (s45) 8P.2-8P. 10.1042/cs101008Pa.

P

Pepys, MB; (2001) Pathogenesis, diagnosis and treatment of systemic amyloidosis. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES , 356 (1406) 203 - 210.

Pepys, MB; (2001) Serum amyloid P component: Normal functions and role in pathogenesis, diagnosis and treatment of amyloidosis. In: AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS. (pp. 23 - 26). PARTHENON PUBLISHING GROUP

Pepys, MB; Hirschfield, GM; (2001) C-reactive protein and atherothrombosis. Ital Heart J , 2 (3) pp. 196-199.

Pepys, MB; Hirschfield, GM; (2001) C-reactive protein and its role in the pathogenesis of myocardial infarction. Ital Heart J , 2 (11) pp. 804-806.

Peto, H; Lindquist, S; Dobson, CM; Perutz, MF; Pepys, M; Goldberg, ME; (2001) Investigating protein conformation-based inheritance and disease in yeast - Discussion. PHILOS T R SOC B , 356 (1406) 176 - 176.

Price, EJ; Hay, EM; Isenberg, DA; Brititish Soc Rheumatology Res Tra, ; (2001) Research and training review of the use of LAS, LAT and flexible training positions. RHEUMATOLOGY , 40 (12) 1413 - 1415.

R

Rahman, A; Haley, J; Radway-Bright, E; Nagl, S; Low, DG; Latchman, DS; Isenberg, DA; (2001) The importance of somatic mutations in the V(lambda) gene 2a2 in human monoclonal anti-DNA antibodies. J Mol Biol , 307 (1) pp. 149-160. 10.1006/jmbi.2000.4491.

S

Silva, C; Isenberg, DA; (2001) Aetiology and pathology of systemic lupus erythematosus. Hospital Pharmacist , 8 pp. 62-68.

Smyth, AE; Denton, CP; Brough, GM; Mukerjee, D; Black, CM; (2001) Prospective comparison of three self-reported disease indices in scleroderma. RHEUMATOLOGY , 40 115 - 115.

Stangou, AJ; Heaton, N; Rela, M; O'Grady, ; Mufti, G; Alexander, GJ; Gillmore, D; ... Hawkins, PN; + view all (2001) Liver transplantation for end stage hepatic amyloidosis. In: (pp. p. 152). INFORMA HEALTHCARE

Stangou, AJ; Heaton, ND; Rela, M; Bradley, JR; Mufti, GJ; Hawkins, PN; (2001) Systemic AL amyloidosis related liver failure; the role of liver transplantation. In: (pp. 312B-312B). AMER SOC HEMATOLOGY

Stangou, AJ; Heaton, ND; Rela, M; O'Grady, J; Westaby, D; Alexander, GJ; Bradwell, JA; ... Hawkins, PN; + view all (2001) Liver transplantation for liver failure in association with AL amyloidosis. In: (pp. 205A-205A). WILEY-BLACKWELL

Sutcliffe, N; Clarke, AE; Taylor, R; Frost, C; Isenberg, DA; (2001) Total costs and predictors of costs in patients with systemic lupus erythematosus. RHEUMATOLOGY , 40 (1) 37 - 47.

T

Tormey, VJ; Bunn, CC; Denton, CP; Black, CM; (2001) Anti-fibrillarin antibodies in systemic sclerosis. Rheumatology (Oxford) , 40 (10) pp. 1157-1162.

V

Vonend, O; Turner, C; Loesch, A; Srai, K; Burnstock, G; Unwin, R; (2001) P2X7 receptor expression in diabetic nephropathy. In: (pp. A4447-).

W

Wan, H; Winton, HL; Soeller, C; Taylor, GW; Gruenert, DC; Thompson, PJ; Cannell, MB; ... Robinson, C; + view all (2001) Disruption of occluding junctions by fecal pellet-derived serine proteases of Dematophagoides pteronyssinius increases permeability of airway epithelial cell monolayers. Clinical and Experimental Allergy , 31 pp. 279-294.

Wechalekar, AD; Sutton, D; Voralia, M; Stewart, AK; Chen, CI; (2001) Intermediate dose thalidomide (200mg daily) has comparable efficacy and less toxicity than higher doses in relapsed multiple myeloma. BLOOD , 98 (11) 162A - 162A.

Wood, SP; Coker, ; A, R; (2001) Purification for Crystallography. In: Simon, R, (ed.) Protein Purification Applications. (pp. 29-47). Oxford University Press

This list was generated on Sun Oct 14 05:00:14 2018 BST.